1.基金项目
(1) 国家自然科学基金青年项目，No. 22305170, 基于仿生脂质纳米疫苗的动脉粥样硬化双重免疫治疗策略及机制研究，主持，2024-2027
(2) 山西省基础研究计划青年项目，No. 202303021222016, ApoB100脂质纳米疫苗对动脉粥样硬化的治疗及其调控Treg细胞机制研究，主持，2024-2027
2.代表性论文
(1) Min Xu, Gege Wu, Qing You, Xiaoyuan Chen. The landscape of smart biomaterial‐based hydrogen therapy. Adv. Sci. DOI: 10.1002/ADVS.202401310.
(2) Min Xu, Xuan Zhang, Baowen Dong, Wenjuan Wang, Zhihuan Zhao. Sustained release of hydrogen by PdH-Te nanozyme for anti-inflammatory therapy against atherosclerosis. Part. Part. Syst. Charact. 2024, 41, 2300135.
(3) Xuan Zhang, Zhihuan Zhao, Min Xu, Shasha Yang, Yiliang Xie, Bing Zhang, Jimin Fan. A curcumin-based MOF embedded Ag NPs and modified with polydopamine for dual-drug delivery and dual biological window responsive synergetic cancer therapy. Part. Part. Syst. Charact. 2023, 40, 2300047.
(4) Min Xu, Yue Zhou, Chuchu Ren, Xiaoyang Liang, Nan Li. Palladium hydride nanopocket cubes and their H2-therapy function in amplifying inhibition of foam cells to attenuate atherosclerosis. Adv. Funct. Mater. 2021, 31, 2104892.
(5) Min Xu, Qianglan Lu, Yilin Song, Lifang Yang, Jining Li, Nan Li. Enhanced Bax upregulating in mitochondria for deep tumor therapy based on SO2 prodrug loaded Au-Ag hollow nanotriangles. Biomaterials 2020, 250, 120076.
(6) Min Xu, Qianglan Lu, Yiling Song, Lifang Yang, Chuchu Ren, Wen Li, Ping Liu, Yule Wang, Yan Zhu, Nan Li. NIR-II driven plasmon-enhanced cascade reaction for tumor microenvironment-regulated catalytic therapy based on bio-breakable Au-Ag nanozyme. Nano Res. 2020, 13, 2118-2129.
(7) Min Xu, Chuchu Ren, Yue Zhou, Zbynek Heger, Xiaoyang Liang, Vojtech Adam, Nan Li. Enhanced macrophage polarization induced by COX-2 inhibitor-loaded Pd octahedral nanozymes for treatment of atherosclerosis. Chin. Chem. Lett. 2023, 34, 107585.
(8) Min Xu, Yiling Song, Jinping Wang, Nan Li. Anisotropic transition metal-based nanomaterials for biomedical applications. VIEW 2021, 20200154.
